• Skip to primary navigation
  • Skip to main content
  • Skip to footer

Susannah Fox

I help people navigate health and technology.

  • Home
  • Rebel Health
  • Blog
    • greatest hits
    • health data
    • peer-to-peer health care
    • public Q&A
  • About me
    • Bio
    • Now
    • Curriculum vitae
  • Events

A genomic literacy spiral?

December 16, 2013 By Susannah Fox 6 Comments

Like many people, I’m intrigued by the 23andme drama. Here’s a quote I scribbled down at Health Foo:

The data and genomics revolution is akin to the print revolution. Hundreds of years ago, peasants looked at this converted wine press and asked why we need more Bibles when nobody can read. The printing press triggered a literacy spiral, with both good and bad publications coming from it. The net result was worth it. That’s the story we need to tell.

For more, see: Gutenberg, Genomics, and the Literacy/Literature Spiral, by Tom Munnecke. Please note that I’m not endorsing his view. I’m interested in it and would love to hear what other people think.

If you’re just tuning in, I’ve found the following articles helpful:

  • The FDA vs. Personal Genetic Testing, by David Dobbs
  • 23andstupid: Is 23andme self-destructing? by Matthew Herper
  • Matthew Katz on 23andMe: “Return to Sender, Genome Unknown: Seven Reasons I Will Return My Personal Genome Kit”

Filed Under: key people, policy issues Tagged With: 23andme, genomics, Health Foo

Reader Interactions

Comments

  1. Brett Alder says

    December 16, 2013 at 1:04 pm

    Thanks for starting the conversation on 23andMe, Susannah. Reading through the articles many of the arguments can be boiled down to “The FDA stands in the way of inexorable progress” or “It’s a good thing and you should be skeptical of 23andMe.”

    A couple of points I haven’t come across yet would be:
    1) This discussion has very little to do with 23andMe as a company. It really doesn’t matter if you like them or dislike them, the real issue is whether consumers have a right to work directly with ANY genetics service company without the FDA as intermediary.
    2) The FDA has the power by law to regulate companies that claim to offer medical diagnoses. IMHO, they are within their purview on this decision. So, instead of focusing on the FDA’s actions, we should turn our attention to a set of laws that only apply to medical interactions. Why do companies offering medical diagnostics have to abide by a special set of laws that don’t apply to other product and service providers? If they’re good laws, then shouldn’t they apply to all interactions? As it is now, we are in this discriminatory place where you can sign a waiver and participate in an extreme sport, but 23andMe can’t show you your genetic predispositions. How many extreme sports would we have if they all had to be FDA approved? I think equality should be a part of the discussion.

    As an ePatient advocate, I think that the more value patients control, the better off they are. As far as I can tell, patients control less value (have fewer choices) as a consequence of not being able to directly contract with genetic services companies.

    Reply
    • Susannah Fox says

      December 17, 2013 at 9:53 am

      Thanks, Brett! Great questions. I haven’t done the research, but I do think there are other companies who offer similar services. They are much less well-known (few have the marketing power that 23andme enjoys).

      As a researcher who studied the social impact of the internet as it emerged — another Gutenberg moment — I am looking for ways to study the emergence of personal genomics. Ideas welcome!

      Reply
      • Brett Alder says

        December 20, 2013 at 1:45 pm

        Yes, that’s right (about 23andMe’s marketing muscle). They’ve had many competitors over the years, but are pulling ahead for now: http://www.quora.com/23andMe/Who-are-23andMes-competitors

        At least in my own patient community several us used 23andMe to do our genotyping, and then we downloaded the information into spreadsheet analysis tools. We didn’t come up with anything, but it’s still early and the tools are rudimentary. I’ve heard it compared to the early days of the semiconductor market — tools were manual and early integrated circuits had very limited utility. Also hoping genomics will be a new Gutenberg moment.

        Reply
  2. Susannah Fox says

    December 19, 2013 at 9:22 am

    I’ll add another article to the reading list:

    23 and You: Does that commercial DNA test you just bought violate somebody else’s privacy? by Virginia Hughes in Matter

    Reply
  3. Brett Alder says

    December 20, 2013 at 2:32 pm

    Thought this Marginal Revolution post was informative:
    http://marginalrevolution.com/marginalrevolution/2013/11/our-dna-our-selves.html

    Reply
  4. Susannah Fox says

    January 9, 2014 at 8:10 am

    Since this blog is my outboard memory, I’ll add a link to Leonard Kish’s article:

    The Social Conquest of Medicine: The 23andMe and Conflict

    It’s more than worth a click.

    Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Footer

Explore

Don't miss a post

Enter your email address and receive notifications of new posts by email.

Topics

  • Seekers
  • Networkers
  • Solvers
  • Champions
  • Health Data
  • Peer-to-Peer Health Care
  • Public Q&A

Recent Comments

  • Susannah Fox on Public Q&A: “I received scary test results. What questions should I ask my clinician?”: “Thanks, Samantha! I love your signature line/bona fides list — you tick the boxes for “learned and loved experience” described…” May 6, 15:33
  • Samantha Bridge on Public Q&A: “I received scary test results. What questions should I ask my clinician?”: “Great conversation. It has been my experience as a nurse to have the conversation before the testing. What is the…” May 4, 09:05
  • Susannah Fox on Rare Disease in the NYT: “Captivated is such a good description of how I felt, too. I read the essay once through quickly, then a…” Apr 25, 11:12

Copyright Susannah Fox © 2025 · WordPress · Log in